Vance Defends Stock Trading Calls for Congressional Ban in Wake of Trump Filings TScan Therapeutics TCRX Q1 2026 Miss What Went Wrong Silver Prices Edge Lower on Rising Bond Yields Fed Anticipation Nathans Famous NATH Q4 2024 Results Meet Expectations Revenue NA